AnaptysBio, Inc. (ANAB)
55.41
-1.87
(-3.26%)
USD |
NASDAQ |
Mar 06, 16:00
55.31
-0.10
(-0.18%)
After-Hours: 05:07
AnaptysBio SG&A Expense (TTM) : 50.74M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 74.62M |
| Rigel Pharmaceuticals, Inc. | 85.91M |
| Vanda Pharmaceuticals, Inc. | 237.95M |
| Esperion Therapeutics, Inc. | 161.28M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |